Filing Flows › Moderna (MRNA) › Who owns the stock
Who owns Moderna (MRNA) stock
819 funds reported Moderna (MRNA) shares in their latest 13F filings, worth $23.8B in all. The largest holder is FMR LLC ($3.6B). Last quarter 341 funds added to their stakes and 298 cut them. Members of Congress and other officials disclosed 3 trades (1 buys, 2 sales).
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| FMR LLC | 51,859,891 | $3.6B | increase | 2026-06-30 |
| BlackRock | 30,599,409 | $2.1B | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 23,208,792 | $1.6B | increase | 2026-06-30 |
| Capital World Investors | 22,276,996 | $1.6B | increase | 2026-06-30 |
| Baillie Gifford | 18,206,778 | $1.3B | decrease | 2026-06-30 |
| Vanguard Group | 41,584,782 | $1.2B | increase | 2025-12-31 |
| State Street | 15,726,193 | $1.1B | increase | 2026-06-30 |
| Vanguard Portfolio Management LLC | 15,581,313 | $1.1B | decrease | 2026-06-30 |
| Geode Capital Management, LLC | 9,710,335 | $679M | increase | 2026-06-30 |
| Morgan Stanley | 9,538,094 | $668M | increase | 2026-06-30 |
| Theleme Partners LLP | 8,057,571 | $564M | increase | 2026-06-30 |
| Two Sigma Investments, LP | 7,193,530 | $504M | decrease | 2026-06-30 |
| Banque Pictet & CIE SA | 2,151,259 | $414M | decrease | 2026-09-30 |
| Invesco | 5,780,299 | $405M | increase | 2026-06-30 |
| Price T Rowe Associates | 5,589,560 | $391M | increase | 2026-06-30 |
Trades by Congress and other officials
| Date | Who | Trade | Amount |
|---|---|---|---|
| 2026-09-24 | Maria Elvira Salazar | partial sale | $1K–$15K |
| 2026-08-19 | Maria Elvira Salazar | partial sale | $1K–$15K |
| 2026-08-19 | Maria Elvira Salazar | purchase | $1K–$15K |
Moderna's latest quarter
Moderna, Q3 2026: revenue $1.3B (+29% year over year), operating margin 9.9%, net earnings $162M, operating cash flow −$1.6B. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most MRNA stock?
By the latest 13F filings: FMR LLC ($3.6B); BlackRock ($2.1B); Vanguard Capital Management LLC ($1.6B); Capital World Investors ($1.6B); Baillie Gifford ($1.3B).
Has Congress traded MRNA stock?
Officials disclosed 3 trades on file: 1 buys and 2 sales. The latest: Maria Elvira Salazar, partial sale on 2026-09-24.
What is the short interest in MRNA?
32,603,398 shares were sold short at the 2026-10-15 settlement, 5.64% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.